2021 American Transplant Congress » BK virus in Kidney Recipients

6:00pm-6:05pm

VP2 MRNA Distinguishes the Direct Injury and Inflammation Effects of Polyoma Virus (BK) Infection from the Cognate TCMR Response That Follows Immunosuppressive Minimization

P. F. Halloran¹, K. Famulski¹, K. S. Madill-Thomsen¹, G. Böhmig², G. Gupta³, M. Myślak⁴, O. Viklicky⁵, &. the INTERCOMEX Study Group⁶

6:05pm-6:10pm

Coexistence of BKPyV Lytic Infection and Viral Integration in the Development of BKPyV Diseases After Renal Transplantation

S. Yan¹, Y. Wang¹, Y. Liu¹, W. Deng¹, Z. Yan¹, J. Xu¹, C. Wu², Y. Miao¹

6:10pm-6:15pm

Duration and Magnitude of BK Viremia Do Not Predict Outcome in Patients After Kidney Transplantation

E. A. Farkash¹, J. T. Rajagopal², M. Vincent², M. D. Doshi³

6:15pm-6:20pm

Donor-Derived Cell-Free DNA Levels Risk-Stratify Polyoma BK Viremia and Associated Clinical Events After Kidney Transplantation – Preliminary Results from ADMIRAL Study

A. Pai¹, L. Bu², J. S. Bromberg³, G. Gupta⁴, I. Moinuddin⁴, T. Alhamad⁵, V. Bowers⁶, S. Ghosh⁷, W. Tian⁷, E. Stites⁸, S. Anand⁹

6:20pm-6:25pm

Characterization of Retransplantation Following Graft Failure Due to Bkvn

K. Nguyen¹, H. Curtis², J. Panichella², H. Resweber³, A. Di Carlo², S. Karhadkar¹

6:25pm-6:30pm

Transcriptomics and Proteomics Profiling of Complement Pathway (cp) Proteins in Biopsies With Polyomavirus Bk Nephropathy (bkvn)

P. Randhawa¹, F. Fei², Y. Huang¹, G. Tseng³, K. Xiao⁴

6:30pm-6:35pm

Efficacy of MAU868, a Novel BKV Neutralizing Monoclonal Antibody (mAb), for the Treatment of Severe BK Virus Nephropathy (BKVN) After Kidney Transplant

S. C. Jordan¹, N. Ammerman², M. Toyoda³, K. Lim², J. R. Abend⁴, A. Patick⁵, M. R. Hodges⁵, A. Vo², S. J. Kovacs⁶

6:35pm-6:40pm

Immunosuppression Reduction Strategies for Polyoma BK Viremia in Kidney Transplant Patients on Belatacept-Based Immunosuppression

O. Roe¹, E. Meredith¹, A. Reid², A. Basu³